Time to Sustained CEA Elevation From Start of First-Line Therapy Predicts Initial Treatment Efficacy and Clinical Outcomes in Lung Adenocarcinoma

An article created on 2026-08-20 16:05:03

#	Наименование новости	Информативность	Дата публикации
1	Sex-Associated Plasma Cell-Free DNA Methylation Patterns in Indonesian Lung Cancer: An Exploratory Study	23.93	20-08-2026
2	Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC	28.75	20-08-2026
3	Prognostic factors for 90-day outcomes in lung cancer patients: a single centre study in 1000 real-world patients	20.25	18-08-2026
4	A Smoking-Independent CT Radiomic Signal Predicts EGFR Mutation in Non-Small-Cell Lung Cancer Under a Pre-Registered, Cross-Validated Design	29.94	19-08-2026
5	Combined Furmonertinib and Intrathecal Chemotherapy for Leptomeningeal Metastasis from Non-Small Cell Lung Cancer: Efficacy, Safety, and CSF Drug Concentrations	16.9	07-08-2026
6	Clinical Outcomes of Epidermal Growth Factor Receptor (EGFR) Mutated Metastatic Non-Small Cell Lung Cancer in Kurdistan Region: A Retrospective Study	17.69	20-08-2026
7	The Role of Alveolar Pneumocytes in the Lung Microenvironment of Osteosarcoma Metastases	12.84	19-08-2026
8	Identification of Plasma LGALS3BP via Proteomics and Development of a Non-invasive Diagnostic Model for Early-Stage Lung Adenocarcinoma	25.78	19-08-2026
9	Immunogenicity evaluation of mutant peptides identified from lung cancer patients	16.25	20-08-2026
10	The Role of LINC00261 in Pancreatic Cancer Progression: Implications for EMT and FOXA2 Regulation	25	20-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 17.69. Источник: www.researchsquare.com.

Найдите то, что Вас интересует